Melanoma: the intersection of molecular targeted therapy and immune checkpoint inhibition

Current Opinion in Immunology
Peter Kar Han LauGrant McArthur

Abstract

Melanoma is at the forefront of development of systemic therapeutics with both molecular targeted therapies and immune checkpoint inhibitors as cornerstones of treatment. Although responses to molecularly targeted therapy is largely from blockade of oncogenic pathways, evidence is emerging of the immunomodulatory effects from BRAF inhibition. Additionally programmed-death-1 (PD-1) inhibitors have revolutionized the treatment of melanoma and are set to pave future improvements in other solid tumors. Combinations of PD-1 inhibitors with novel immune checkpoints or with molecularly targeted therapies are under investigation and may improve on the considerable progress made.

References

Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Jun 28, 2006·The Journal of Experimental Medicine·Hidetoshi SumimotoYutaka Kawakami
Jul 4, 2007·International Immunology·Taku Okazaki, Tasuku Honjo
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Feb 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Georgina V LongRichard F Kefford
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Nov 10, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick A OberholzerLevi A Garraway
Dec 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James S WilmottRichard A Scolyer
Jan 13, 2012·Current Opinion in Immunology·Suzanne L TopalianDrew M Pardoll
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grant A McArthurRodney J Hicks
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Oct 26, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaofeng JiangF Stephen Hodi
Jan 1, 2013·The Journal of Molecular Diagnostics : JMD·Wesley O GreavesRajyalakshmi Luthra
Jan 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dennie T FrederickJennifer A Wargo
Mar 9, 2013·Nature Reviews. Immunology·Lieping Chen, Dallas B Flies
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Oct 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Karen E Sheppard, Grant A McArthur
Nov 23, 2013·Cancer Discovery·Hubing ShiRoger S Lo
Nov 23, 2013·Cancer Discovery·Eliezer M Van AllenUNKNOWN Dermatologic Cooperative Oncology Group of Germany (DeCOG)
Jan 28, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Helen RizosGeorgina V Long
Sep 30, 2014·The New England Journal of Medicine·James LarkinAntoni Ribas
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Jan 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Li LiuAxel Hoos
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfJedd D Wolchok
Mar 31, 2015·Seminars in Cancer Biology·Dass S VinayByoung S Kwon
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
May 9, 2015·The Veterinary Record·Martin Atkinson
Jun 2, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok
Jun 20, 2015·Cell·UNKNOWN Cancer Genome Atlas Network
Sep 24, 2015·The New England Journal of Medicine·James LarkinJedd D Wolchok

❮ Previous
Next ❯

Citations

Dec 19, 2016·American Journal of Clinical Dermatology·Praveen K BommareddyHoward L Kaufman
Jan 7, 2017·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Ester SimeonePaolo A Ascierto
Jul 28, 2018·Cancer Immunology, Immunotherapy : CII·Raj K KurupatiHildegund C J Ertl
Mar 31, 2019·Dermatology and Therapy·Dominika KwiatkowskaAdam Reich
Jun 5, 2020·OncoTargets and Therapy·Shanshan NieHongwei Lu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.